BIRMINGHAM, Ala. — For the last 12 years, Texas angler Brad Whatley has dealt with the autoimmune disorder known as Crohn’s disease. Fortunately, over the last eight to nine years, the disease was in remission and caused him few issues — until the beginning of 2022.
Earlier this year, the disease flared up again, causing excruciating pain. The flare-up was bad enough that Whatley spent several days in the hospital in January, just before the start of the Bassmaster Elite Series season, and he has been forced to go back to the hospital four times since then.
After battling the pain through the first four events of the season, the two-time Classic qualifier will take a medical hardship and focus on getting the disease back in remission.
“Out of the four events I’ve fished this season on the Elites, two of them I had absolutely no business being out there,” said Whatley. “I’ve had to miss a quarter of the practices this season because I just physically couldn’t do it. I’ve tried to battle through it, but at the end of the day, it’s taken its toll on me.”
Since the flare-ups began again, Whatley was placed on new medication, and he feels confident that this will help get him back to better health.
“This new medicine will hopefully put it back in remission and I can get back to who I was,” said Whatley. “I’m never truly 100% because there’s no cure for Crohn’s, but as long as I can get back in remission and avoid these major flare-ups, I’ll be good to get back out there.”
